Business Description
Aceso Life Science Group Ltd
ISIN : KYG4289B1106
Total Employee Number:
41Compare
Compare
Traded in other countries / regions
00474.Hong Kong IPO Date
2006-06-06Description
Aceso Life Science Group Ltd is an investment holding company. The group's operating segments include Money lending, Rental and sale of construction machinery and spare parts business, Provision of repair and maintenance and transportation service business, Provision of asset management, securities brokerage, commodities, futures, and other financial service business, Property leasing business, and Property development business. It derives key revenue from the rental and sale of construction machinery and spare parts. Geographically, the group has a business presence in Hong Kong, the UK, the PRC, Macau, and Cambodia.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.25 | |||||
Equity-to-Asset | 0.22 | |||||
Debt-to-Equity | 3.25 | |||||
Debt-to-EBITDA | -2.91 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -3 | |||||
Beneish M-Score | -4.43 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -13.7 | |||||
3-Year EBITDA Growth Rate | -38.3 | |||||
3-Year EPS without NRI Growth Rate | -317.9 | |||||
3-Year FCF Growth Rate | -61.5 | |||||
3-Year Book Growth Rate | -80.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.11 | |||||
9-Day RSI | 50.25 | |||||
14-Day RSI | 51.11 | |||||
3-1 Month Momentum % | 3.64 | |||||
6-1 Month Momentum % | -7.32 | |||||
12-1 Month Momentum % | 470 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.98 | |||||
Quick Ratio | 1.97 | |||||
Cash Ratio | 1.33 | |||||
Days Inventory | 6.95 | |||||
Days Sales Outstanding | 226.38 | |||||
Days Payable | 17.38 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 46.15 | |||||
Operating Margin % | -28.86 | |||||
Net Margin % | -185.08 | |||||
EBITDA Margin % | -205.97 | |||||
FCF Margin % | 57.71 | |||||
OCF Margin % | 57.21 | |||||
ROE % | -94.5 | |||||
ROA % | -11.94 | |||||
ROIC % | -1.53 | |||||
3-Year ROIIC % | 2.02 | |||||
ROC (Joel Greenblatt) % | -279.73 | |||||
ROCE % | -24.25 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4.07 | |||||
PB Ratio | 2.28 | |||||
Price-to-Tangible-Book | 2.28 | |||||
Price-to-Free-Cash-Flow | 7.13 | |||||
Price-to-Operating-Cash-Flow | 7.13 | |||||
EV-to-EBIT | -4.61 | |||||
EV-to-EBITDA | -4.61 | |||||
EV-to-Revenue | 9.5 | |||||
EV-to-FCF | 16.46 | |||||
Price-to-GF-Value | 1.43 | |||||
Price-to-Projected-FCF | 11.4 | |||||
Price-to-Median-PS-Value | 1.04 | |||||
Earnings Yield (Greenblatt) % | -21.69 | |||||
FCF Yield % | 11.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aceso Life Science Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 201 | ||
| EPS (TTM) (HK$) | -0.052 | ||
| Beta | 0.572 | ||
| 3-Year Sharpe Ratio | 0.35 | ||
| 3-Year Sortino Ratio | 1.26 | ||
| Volatility % | 283.94 | ||
| 14-Day RSI | 51.11 | ||
| 14-Day ATR (HK$) | 0.000865 | ||
| 20-Day SMA (HK$) | 0.114 | ||
| 12-1 Month Momentum % | 470 | ||
| 52-Week Range (HK$) | 0.018 - 0.138 | ||
| Shares Outstanding (Mil) | 8,858.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aceso Life Science Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aceso Life Science Group Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| 1.16667:1 Stock Split | 2017-07-12 | 0.27 (+1.61%) | ||
| 1.1:1 Stock Split | 2016-01-21 | 0.30 (+1.33%) | ||
| 0.1:1 Stock Split | 2014-07-31 | 1.33 (+84.03%) |
Show
Entries
Aceso Life Science Group Ltd Frequently Asked Questions
What is Aceso Life Science Group Ltd(HKSE:00474)'s stock price today?
The current price of HKSE:00474 is HK$0.11. The 52 week high of HKSE:00474 is HK$0.14 and 52 week low is HK$0.02.
When is next earnings date of Aceso Life Science Group Ltd(HKSE:00474)?
The next earnings date of Aceso Life Science Group Ltd(HKSE:00474) is .
Does Aceso Life Science Group Ltd(HKSE:00474) pay dividends? If so, how much?
Aceso Life Science Group Ltd(HKSE:00474) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Aceso Life Science Group Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers